Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.12 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.46.
Market Cap
8.12T
Revenue
4.59T
Profits
200.82B
PE Ratio
40.46
Profit Margin
4.38%
Dividend Yield
0.43%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 862.31B | 1.95% | 3,517,455 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 533.03B | 0.05% | 6,223,182 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 358.27B | 0.61% | 4,931,664 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 349.13B | 1.17% | 6,949,607 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 285.79B | -0.54% | 2,106,701 | 60.44B |
| 6 | NVS | Novartis AG | 279.16B | -0.55% | 2,098,902 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 274.84B | -0.09% | 7,750,595 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 209.66B | 0.72% | 17,851,624 | 50.57B |
| 9 | AMGN | Amgen Inc. | 177.88B | -0.64% | 1,918,848 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 168.20B | -2.67% | 3,953,047 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 165.77B | 1.67% | 5,384,970 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 148.77B | -6.67% | 4,032,892 | 10.58B |
| 13 | PFE | Pfizer Inc. | 147.10B | 0.51% | 43,557,962 | 63.32B |
| 14 | ABT | Abbott Laboratories | 143.80B | -2.09% | 16,460,500 | 45.13B |
| 15 | DHR | Danaher Corporation | 117.86B | -2.71% | 7,378,510 | 24.78B |
| 16 | CVS | CVS Health Corporation | 117.67B | 1.84% | 12,024,381 | 405.62B |
| 17 | BMY | Bristol-Myers Squibb Company | 113.68B | -0.87% | 8,390,896 | 48.48B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 110.45B | 1.24% | 1,264,202 | 12.22B |
| 19 | SYK | Stryker Corporation | 108.22B | -1.01% | 2,619,763 | 25.27B |
| 20 | SNY | Sanofi | 103.56B | -1.87% | 5,057,785 | 54.60B |
| 21 | GSK | GSK plc | 100.49B | -1.19% | 3,575,532 | 43.29B |
| 22 | MDT | Medtronic plc | 95.70B | -2.11% | 10,495,718 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 94.59B | -2.03% | 2,414,077 | 76.39B |
| 24 | MCK | McKesson Corporation | 87.17B | -1.48% | 1,693,268 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 82.90B | 0.97% | 1,947,444 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 79.33B | -1.04% | 21,607,609 | 20.61B |
| 27 | CI | The Cigna Group | 76.47B | 0.35% | 1,695,803 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 72.52B | -0.30% | 1,227,187 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 51.94B | -0.61% | 5,164,421 | 28.48B |
| 30 | MDLN | Medline Inc. | 51.56B | -0.68% | 7,480,145 | 29.14B |
| 31 | ARGX | argenx SE | 50.65B | 3.98% | 497,993 | 4.74B |
| 32 | COR | Cencora, Inc. | 50.53B | -0.53% | 2,775,429 | 328.68B |
| 33 | EW | Edwards Lifesciences Corporation | 44.43B | -3.49% | 5,262,032 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 42.74B | -0.63% | 2,012,675 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 41.97B | -5.02% | 761,447 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 41.73B | 0.31% | 5,872,125 | 17.35B |
| 37 | HLN | Haleon plc | 39.64B | -1.43% | 12,119,569 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 39.44B | -4.20% | 3,588,608 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.03B | -3.46% | 1,287,797 | 4.29B |
| 40 | ONC | BeOne Medicines AG | 34.55B | -0.44% | 346,711 | 5.70B |
| 41 | WAT | Waters Corporation | 34.17B | -1.99% | 1,074,387 | 3.77B |
| 42 | HUM | Humana Inc. | 32.93B | -0.25% | 2,485,070 | 137.20B |
| 43 | ZTS | Zoetis Inc. | 32.14B | -7.44% | 15,641,084 | 9.53B |
| 44 | A | Agilent Technologies, Inc. | 31.50B | -3.60% | 2,179,627 | 7.07B |
| 45 | RVMD | Revolution Medicines, Inc. | 30.65B | 1.65% | 1,640,885 | - |
| 46 | ALC | Alcon Inc. | 30.59B | -0.86% | 3,167,486 | 10.63B |
| 47 | RPRX | Royalty Pharma plc | 29.74B | 1.69% | 4,047,064 | 2.44B |
| 48 | BIIB | Biogen Inc. | 29.22B | 2.33% | 1,772,229 | 9.94B |
| 49 | IQV | IQVIA Holdings Inc. | 28.97B | -2.89% | 1,569,362 | 16.63B |
| 50 | RMD | ResMed Inc. | 28.83B | -3.87% | 1,805,478 | 5.54B |
| 51 | NTRA | Natera, Inc. | 28.52B | 2.52% | 2,041,865 | 2.50B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 28.07B | -2.79% | 6,074,298 | 20.98B |
| 53 | CNC | Centene Corporation | 27.83B | 0.71% | 5,959,879 | 178.33B |
| 54 | VEEV | Veeva Systems Inc. | 26.02B | -4.21% | 2,382,131 | 3.20B |
| 55 | PHG | Koninklijke Philips N.V. | 25.70B | -1.76% | 1,488,684 | 20.34B |
| 56 | UTHR | United Therapeutics Corporation | 24.19B | 0.87% | 460,696 | 3.17B |
| 57 | BNTX | BioNTech SE | 23.60B | -0.84% | 647,776 | 3.23B |
| 58 | DXCM | DexCom, Inc. | 22.89B | -2.11% | 5,272,515 | 4.82B |
| 59 | WST | West Pharmaceutical Services, Inc. | 22.77B | -1.11% | 879,387 | 3.22B |
| 60 | INSM | Insmed Incorporated | 22.52B | 2.51% | 7,898,446 | 819.56M |
| 61 | MTD | Mettler-Toledo International Inc. | 21.79B | -4.08% | 316,705 | 4.09B |
| 62 | ILMN | Illumina, Inc. | 21.56B | 0.44% | 2,063,653 | 4.39B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.01B | 1.29% | 620,699 | 11.28B |
| 64 | MRNA | Moderna, Inc. | 20.98B | -2.70% | 25,402,172 | 2.23B |
| 65 | LH | Labcorp Holdings Inc. | 20.92B | 0.38% | 677,621 | 14.14B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.73B | 1.40% | 4,199,138 | 13.31M |
| 67 | INCY | Incyte Corporation | 20.04B | 1.79% | 1,662,288 | 5.36B |
| 68 | STE | STERIS plc | 19.80B | -2.70% | 1,025,854 | 5.94B |
| 69 | VTRS | Viatris Inc. | 19.70B | -1.46% | 14,119,500 | 14.56B |
| 70 | THC | Tenet Healthcare Corporation | 16.51B | 0.68% | 962,133 | 21.46B |
| 71 | GMAB | Genmab A/S | 16.06B | -0.95% | 2,646,904 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 15.40B | -3.34% | 2,229,822 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.14B | -1.09% | 1,216,876 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.82B | - | 682,349 | 998.25M |
| 75 | SMMT | Summit Therapeutics Inc. | 14.48B | 3.21% | 4,233,584 | - |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.03B | -0.97% | 997,701 | 4.44B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 13.51B | -6.66% | 109,564 | - |
| 78 | SOLV | Solventum Corporation | 12.84B | 1.01% | 1,989,098 | 8.26B |
| 79 | GH | Guardant Health, Inc. | 12.82B | 1.06% | 2,027,744 | 1.08B |
| 80 | DVA | DaVita Inc. | 12.77B | 0.14% | 1,106,603 | 13.84B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 12.67B | -4.02% | 3,648,394 | 579.96M |
| 82 | PEN | Penumbra, Inc. | 12.65B | -0.16% | 351,888 | 1.45B |
| 83 | SNN | Smith & Nephew plc | 12.51B | -2.84% | 1,447,136 | 6.16B |
| 84 | EXEL | Exelixis, Inc. | 12.49B | 3.22% | 3,831,187 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.46B | -0.44% | 1,533,667 | 1.06B |
| 86 | MEDP | Medpace Holdings, Inc. | 11.92B | -1.58% | 405,166 | 2.68B |
| 87 | FMS | Fresenius Medical Care AG | 11.80B | -1.23% | 859,178 | 22.32B |
| 88 | ALGN | Align Technology, Inc. | 11.79B | -2.47% | 1,129,357 | 4.10B |
| 89 | COO | The Cooper Companies, Inc. | 11.51B | -1.70% | 1,697,160 | 4.15B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -2.55% | 307,741 | 1.13B |
| 91 | BTSG | BrightSpring Health Services, Inc. | 11.33B | 0.44% | 2,471,995 | 13.65B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.18B | -0.68% | 3,363,288 | 3.85B |
| 93 | AXSM | Axsome Therapeutics, Inc. | 11.14B | -0.42% | 738,195 | 708.24M |
| 94 | RVTY | Revvity, Inc. | 11.06B | -2.03% | 1,600,922 | 2.90B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.95B | 6.95% | 2,290,058 | 622.01M |
| 96 | ELAN | Elanco Animal Health Incorporated | 10.85B | -8.16% | 8,236,435 | 4.89B |
| 97 | PODD | Insulet Corporation | 10.68B | 0.01% | 1,536,228 | 2.90B |
| 98 | GMED | Globus Medical, Inc. | 10.41B | -1.63% | 2,697,030 | 3.10B |
| 99 | EHC | Encompass Health Corporation | 10.40B | -1.21% | 576,815 | 6.07B |
| 100 | UHS | Universal Health Services, Inc. | 10.18B | -1.02% | 959,815 | 17.76B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.16B | -2.74% | 2,466,506 | 3.24B |
| 102 | ENSG | The Ensign Group, Inc. | 9.82B | -1.19% | 798,471 | 5.27B |
| 103 | ABVX | ABIVAX Société Anonyme | 9.71B | -0.50% | 678,111 | 5.37M |
| 104 | MOH | Molina Healthcare, Inc. | 9.65B | -0.40% | 1,038,860 | 43.10B |
| 105 | MASI | Masimo Corporation | 9.35B | 0.11% | 833,052 | 1.56B |
| 106 | CYTK | Cytokinetics, Incorporated | 9.28B | -3.06% | 5,316,878 | 105.82M |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 9.25B | 0.54% | 749,052 | 7.46M |
| 108 | KRYS | Krystal Biotech, Inc. | 9.22B | 2.35% | 386,636 | 417.30M |
| 109 | ICLR | ICON Public Limited Company | 9.08B | -4.44% | 824,482 | 8.10B |
| 110 | BAX | Baxter International Inc. | 9.05B | -2.56% | 7,239,901 | 11.32B |
| 111 | TEM | Tempus AI, Inc. | 8.70B | -2.81% | 8,238,992 | 1.36B |
| 112 | IBRX | ImmunityBio, Inc. | 8.49B | -4.70% | 14,502,080 | 140.98M |
| 113 | NUVL | Nuvalent, Inc. | 8.26B | -0.69% | 334,572 | - |
| 114 | CRL | Charles River Laboratories International, Inc. | 8.11B | -5.16% | 762,281 | 4.03B |
| 115 | GKOS | Glaukos Corporation | 7.95B | 1.39% | 814,293 | 551.35M |
| 116 | HALO | Halozyme Therapeutics, Inc. | 7.87B | 3.57% | 2,923,099 | 1.51B |
| 117 | HSIC | Henry Schein, Inc. | 7.86B | -2.58% | 2,069,122 | 13.38B |
| 118 | PCVX | Vaxcyte, Inc. | 7.80B | 1.85% | 1,514,859 | - |
| 119 | ATR | AptarGroup, Inc. | 7.66B | -0.85% | 706,134 | 3.87B |
| 120 | TECH | Bio-Techne Corporation | 7.42B | -1.94% | 2,706,682 | 1.21B |
| 121 | KYMR | Kymera Therapeutics, Inc. | 6.92B | -2.30% | 486,222 | 51.48M |
| 122 | HQY | HealthEquity, Inc. | 6.90B | -3.76% | 673,740 | 1.31B |
| 123 | QGEN | Qiagen N.V. | 6.75B | -1.24% | 1,832,641 | 2.10B |
| 124 | HIMS | Hims & Hers Health, Inc. | 6.73B | 3.08% | 61,192,950 | 2.37B |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 6.66B | 4.17% | 572,035 | 74.06M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 6.64B | 1.84% | 1,333,266 | - |
| 127 | OSCR | Oscar Health, Inc. | 6.63B | 3.24% | 8,407,839 | 13.30B |
| 128 | BRKR | Bruker Corporation | 6.59B | -2.02% | 2,778,948 | 3.46B |
| 129 | RGEN | Repligen Corporation | 6.54B | -6.12% | 1,283,839 | 763.34M |
| 130 | BIO | Bio-Rad Laboratories, Inc. | 6.52B | -4.14% | 430,848 | 2.59B |
| 131 | MIRM | Mirum Pharmaceuticals, Inc. | 6.47B | -0.92% | 528,495 | 569.61M |
| 132 | GRFS | Grifols, S.A. | 6.45B | -3.70% | 829,812 | 8.58B |
| 133 | PTCT | PTC Therapeutics, Inc. | 6.37B | 4.29% | 3,208,950 | 827.11M |
| 134 | APGE | Apogee Therapeutics, Inc. | 6.34B | 1.89% | 983,941 | - |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.13B | - | 974,665 | 15.00M |
| 136 | LNTH | Lantheus Holdings, Inc. | 6.12B | 1.09% | 1,190,359 | 1.55B |
| 137 | CGON | CG Oncology, Inc. | 6.11B | -0.43% | 789,987 | 5.07M |
| 138 | TGTX | TG Therapeutics, Inc. | 6.11B | 0.65% | 2,782,188 | 700.35M |
| 139 | CELC | Celcuity Inc. | 6.07B | -4.14% | 946,692 | - |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.99B | -7.20% | 1,198,694 | 217.17M |
| 141 | BLTE | Belite Bio, Inc | 5.98B | -1.88% | 67,289 | - |
| 142 | IMVT | Immunovant, Inc. | 5.91B | 0.41% | 1,150,859 | - |
| 143 | ALKS | Alkermes plc | 5.91B | 1.37% | 2,323,470 | 1.56B |
| 144 | COGT | Cogent Biosciences, Inc. | 5.83B | -1.84% | 1,070,868 | - |
| 145 | SRRK | Scholar Rock Holding Corporation | 5.79B | -0.08% | 1,005,201 | - |
| 146 | TFX | Teleflex Incorporated | 5.74B | -2.51% | 857,312 | 2.13B |
| 147 | BLCO | Bausch + Lomb Corporation | 5.71B | -0.93% | 780,502 | 5.10B |
| 148 | CHE | Chemed Corporation | 5.57B | -0.67% | 170,083 | 2.54B |
| 149 | CORT | Corcept Therapeutics Incorporated | 5.50B | -2.07% | 1,325,133 | 769.10M |
| 150 | AVTR | Avantor, Inc. | 5.44B | -4.09% | 6,731,114 | 6.55B |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.39B | -1.17% | 714,926 | 7.50M |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.02% | 9,021,713 | 1.11B |
| 153 | CRSP | CRISPR Therapeutics AG | 5.21B | -1.50% | 1,317,773 | 4.10M |
| 154 | PACS | PACS Group, Inc. | 5.01B | -5.03% | 1,023,654 | 5.43B |
| 155 | STVN | Stevanato Group S.p.A. | 4.99B | 0.27% | 451,187 | 1.39B |
| 156 | BLLN | BillionToOne, Inc. | 4.87B | 13.96% | 1,098,288 | 354.54M |
| 157 | DOCS | Doximity, Inc. | 4.85B | 1.08% | 4,192,657 | 637.78M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.76B | 0.47% | 254,980 | 1.34M |
| 159 | LEGN | Legend Biotech Corporation | 4.73B | -9.03% | 3,048,694 | 1.03B |
| 160 | LQDA | Liquidia Corporation | 4.72B | 25.60% | 6,900,133 | 288.07M |
| 161 | NAMS | NewAmsterdam Pharma Company N.V. | 4.55B | 2.22% | 3,163,006 | 22.57M |
| 162 | CAI | Caris Life Sciences, Inc. | 4.51B | -1.30% | 3,256,056 | 907.29M |
| 163 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.49B | -0.39% | 399,174 | 754.05M |
| 164 | MANE | Veradermics, Incorporated | 4.45B | 1.87% | 386,699 | - |
| 165 | LGND | Ligand Pharmaceuticals Incorporated | 4.42B | -0.42% | 204,248 | 274.48M |
| 166 | SHC | Sotera Health Company | 4.40B | -2.22% | 3,025,818 | 1.19B |
| 167 | RDNT | RadNet, Inc. | 4.38B | -3.94% | 2,415,895 | 2.14B |
| 168 | HNGE | Hinge Health, Inc. | 4.24B | -2.28% | 1,782,088 | 646.34M |
| 169 | AMRX | Amneal Pharmaceuticals, Inc. | 4.08B | -3.18% | 1,637,629 | 3.05B |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.05B | 2.14% | 2,455,899 | 536.20M |
| 171 | NVST | Envista Holdings Corporation | 3.94B | -0.17% | 5,032,823 | 2.81B |
| 172 | ORKA | Oruka Therapeutics, Inc. | 3.93B | 1.69% | 937,835 | - |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.85B | -2.48% | 1,927,289 | 18.07M |
| 174 | LIVN | LivaNova PLC | 3.85B | -2.46% | 1,085,061 | 1.43B |
| 175 | IRTC | iRhythm Holdings, Inc. | 3.84B | -3.17% | 485,408 | 787.85M |
| 176 | WAY | Waystar Holding Corp. | 3.82B | -6.92% | 2,120,864 | 1.16B |
| 177 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.80B | - | 3,684,016 | 596.96M |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 3.73B | -2.68% | 1,944,009 | 1.10B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.72B | -2.15% | 1,096,571 | - |
| 180 | VKTX | Viking Therapeutics, Inc. | 3.68B | 1.24% | 1,960,780 | - |
| 181 | TLX | Telix Pharmaceuticals Limited | 3.68B | 1.40% | 162,366 | 803.79M |
| 182 | MMSI | Merit Medical Systems, Inc. | 3.60B | -1.57% | 960,734 | 1.54B |
| 183 | ALHC | Alignment Healthcare, Inc. | 3.55B | -4.29% | 7,621,545 | 4.26B |
| 184 | WRBY | Warby Parker Inc. | 3.53B | -2.57% | 4,224,735 | 890.57M |
| 185 | OGN | Organon & Co. | 3.50B | - | 4,928,154 | 6.16B |
| 186 | TWST | Twist Bioscience Corporation | 3.50B | -1.13% | 1,146,681 | 409.48M |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.39B | 2.00% | 1,143,861 | 62.38M |
| 188 | ERAS | Erasca, Inc. | 3.25B | 3.16% | 3,804,401 | - |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.20B | 3.48% | 1,139,293 | 2.23B |
| 190 | VCYT | Veracyte, Inc. | 3.17B | -1.78% | 995,001 | 541.74M |
| 191 | BEAM | Beam Therapeutics Inc. | 3.16B | -1.76% | 2,410,398 | 164.01M |
| 192 | MMED | MiniMed Group, Inc. | 3.13B | -3.54% | 579,487 | 2.99B |
| 193 | RCUS | Arcus Biosciences, Inc. | 3.13B | -1.97% | 637,931 | 236.00M |
| 194 | DNLI | Denali Therapeutics Inc. | 3.12B | 0.25% | 1,834,085 | - |
| 195 | ICUI | ICU Medical, Inc. | 3.12B | -1.38% | 403,162 | 2.16B |
| 196 | OPCH | Option Care Health, Inc. | 3.11B | -3.32% | 4,827,559 | 5.67B |
| 197 | BKD | Brookdale Senior Living Inc. | 3.06B | -1.31% | 4,741,353 | 3.00B |
| 198 | DYN | Dyne Therapeutics, Inc. | 3.05B | 4.83% | 1,182,037 | - |
| 199 | ALMS | Alumis Inc. | 3.01B | - | 962,797 | 24.05M |
| 200 | LFST | LifeStance Health Group, Inc. | 2.97B | -0.39% | 12,999,189 | 1.49B |
| 201 | KLRA | Kailera Therapeutics, Inc. | 2.97B | 6.80% | 482,933 | - |
| 202 | NHC | National HealthCare Corporation | 2.96B | 0.49% | 89,528 | 1.53B |
| 203 | ITGR | Integer Holdings Corporation | 2.88B | -3.71% | 535,992 | 1.86B |
| 204 | PRVA | Privia Health Group, Inc. | 2.87B | -1.30% | 1,286,926 | 2.25B |
| 205 | SUPN | Supernus Pharmaceuticals, Inc. | 2.87B | -4.19% | 853,179 | 776.83M |
| 206 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -0.02% | 1,484,437 | 285.01M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.72B | -1.99% | 694,844 | - |
| 208 | ARQT | Arcutis Biotherapeutics, Inc. | 2.66B | 0.33% | 3,327,292 | 415.62M |
| 209 | NKTR | Nektar Therapeutics | 2.66B | -3.87% | 1,748,078 | 55.63M |
| 210 | IRON | Disc Medicine, Inc. | 2.64B | 1.42% | 518,544 | - |
| 211 | GRAL | GRAIL, Inc. | 2.63B | -0.62% | 588,909 | 156.12M |
| 212 | VERA | Vera Therapeutics, Inc. | 2.63B | 1.16% | 1,147,622 | - |
| 213 | IMNM | Immunome, Inc. | 2.60B | 2.50% | 1,277,787 | 6.94M |
| 214 | TXG | 10x Genomics, Inc. | 2.60B | -5.09% | 2,885,165 | 638.78M |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 2.58B | 0.69% | 1,861,673 | 670.00M |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | -2.55% | 1,268,480 | 535.08M |
| 217 | HTFL | HeartFlow, Inc. | 2.53B | -0.41% | 844,154 | 176.03M |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -4.97% | 960,369 | 865.00K |
| 219 | KOD | Kodiak Sciences Inc. | 2.49B | -2.83% | 1,261,870 | - |
| 220 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -0.67% | 1,085,121 | 225.27M |
| 221 | RLAY | Relay Therapeutics, Inc. | 2.46B | 0.71% | 3,228,409 | 10.68M |
| 222 | MLYS | Mineralys Therapeutics, Inc. | 2.45B | 0.64% | 718,916 | - |
| 223 | HAE | Haemonetics Corporation | 2.43B | -5.22% | 1,021,908 | 1.33B |
| 224 | NBTX | Nanobiotix S.A. | 2.41B | 17.72% | 203,754 | 38.27M |
| 225 | ELVN | Enliven Therapeutics, Inc. | 2.41B | -2.85% | 705,307 | - |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.40B | -3.60% | 869,092 | 1.10B |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.33B | -2.95% | 1,482,854 | - |
| 228 | LMAT | LeMaitre Vascular, Inc. | 2.32B | -5.84% | 410,569 | 256.28M |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | -0.68% | 1,706,676 | 3.37B |
| 230 | GRDN | Guardian Pharmacy Services, Inc. | 2.26B | -1.22% | 287,058 | 1.46B |
| 231 | HCM | HUTCHMED (China) Limited | 2.24B | -1.98% | 37,666 | 548.51M |
| 232 | TMDX | TransMedics Group, Inc. | 2.22B | -5.22% | 3,167,629 | 635.89M |
| 233 | ZLAB | Zai Lab Limited | 2.20B | 5.32% | 984,229 | 453.28M |
| 234 | XRAY | DENTSPLY SIRONA Inc. | 2.19B | -0.82% | 6,231,421 | 3.68B |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.18B | -0.46% | 3,710,142 | 885.72M |
| 236 | AXGN | Axogen, Inc. | 2.17B | -3.02% | 1,338,080 | 238.11M |
| 237 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | -1.96% | 1,505,375 | 295.41M |
| 238 | ASTH | Astrana Health, Inc. | 2.12B | -3.38% | 561,086 | 3.53B |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.11B | 2.62% | 1,131,889 | - |
| 240 | ESTA | Establishment Labs Holdings Inc. | 2.10B | -0.38% | 313,567 | 229.58M |
| 241 | NVCR | NovoCure Limited | 2.10B | 1.17% | 2,593,329 | 674.41M |
| 242 | SION | Sionna Therapeutics, Inc. | 2.07B | 3.89% | 670,726 | - |
| 243 | SRPT | Sarepta Therapeutics, Inc. | 2.05B | -2.81% | 3,072,520 | 2.18B |
| 244 | SEM | Select Medical Holdings Corporation | 2.04B | 0.18% | 1,128,102 | 5.52B |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.03B | -0.76% | 461,074 | 32.08M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.03B | -3.83% | 3,520,981 | 52.04M |
| 247 | TYRA | Tyra Biosciences, Inc. | 2.02B | -0.90% | 407,926 | - |
| 248 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 3.22% | 2,182,663 | 298.30M |
| 249 | NTLA | Intellia Therapeutics, Inc. | 2.01B | 2.34% | 7,237,854 | 66.09M |
| 250 | BHC | Bausch Health Companies Inc. | 2.01B | -6.61% | 2,037,499 | 10.53B |
| 251 | AAPG | Ascentage Pharma Group International | 2.00B | 0.74% | 1,455 | 82.08M |
| 252 | OMCL | Omnicell, Inc. | 1.97B | -1.19% | 381,604 | 1.23B |
| 253 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | 0.15% | 1,770,161 | 7.47M |
| 254 | PHVS | Pharvaris N.V. | 1.96B | -0.47% | 844,065 | - |
| 255 | ANAB | AnaptysBio, Inc. | 1.95B | -2.03% | 504,139 | 234.60M |
| 256 | OCS | Oculis Holding AG | 1.93B | 0.03% | 629,010 | 1.51M |
| 257 | MBX | MBX Biosciences, Inc. | 1.91B | -2.17% | 1,886,135 | - |
| 258 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | -0.51% | 2,157,192 | 217.17M |
| 259 | NEOG | Neogen Corporation | 1.88B | -4.42% | 2,080,594 | 870.56M |
| 260 | MESO | Mesoblast Limited | 1.88B | -1.56% | 139,254 | 65.38M |
| 261 | MD | Pediatrix Medical Group, Inc. | 1.87B | -0.60% | 821,762 | 1.93B |
| 262 | INBX | Inhibrx Biosciences, Inc. | 1.86B | -5.04% | 1,330,089 | 1.30M |
| 263 | CAPR | Capricor Therapeutics, Inc. | 1.85B | 5.00% | 1,671,314 | 11.13M |
| 264 | RAPP | Rapport Therapeutics, Inc. | 1.84B | 1.03% | 548,106 | 20.00M |
| 265 | GENB | Generate Biomedicines, Inc. | 1.83B | 5.20% | 358,921 | 30.30M |
| 266 | ADMA | ADMA Biologics, Inc. | 1.83B | -3.55% | 8,592,928 | 509.86M |
| 267 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -3.99% | 194,448 | 1.20B |
| 268 | AHG | Akso Health Group | 1.81B | 6.57% | 188,984 | 14.84M |
| 269 | ANIP | ANI Pharmaceuticals, Inc. | 1.79B | -3.85% | 895,758 | 923.71M |
| 270 | ADUS | Addus HomeCare Corporation | 1.79B | -1.79% | 414,093 | 1.45B |
| 271 | SGRY | Surgery Partners, Inc. | 1.79B | -4.57% | 1,039,400 | 3.34B |
| 272 | VRDN | Viridian Therapeutics, Inc. | 1.77B | 3.55% | 3,205,722 | 70.92M |
| 273 | PGNY | Progyny, Inc. | 1.77B | -4.93% | 2,905,940 | 1.29B |
| 274 | ZYME | Zymeworks Inc. | 1.75B | 0.59% | 1,185,233 | 81.26M |
| 275 | PVLA | Palvella Therapeutics, Inc. | 1.75B | 0.66% | 338,981 | - |
| 276 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | -2.61% | 796,424 | 899.11M |
| 277 | QURE | uniQure N.V. | 1.74B | -0.07% | 2,694,754 | 18.09M |
| 278 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -1.81% | 14,017,304 | 66.41M |
| 279 | SNDA | Sonida Senior Living, Inc. | 1.72B | -3.42% | 977,705 | 367.34M |
| 280 | UFPT | UFP Technologies, Inc. | 1.72B | -3.72% | 227,873 | 608.85M |
| 281 | GLUE | Monte Rosa Therapeutics, Inc. | 1.71B | 4.49% | 1,042,714 | 42.95M |
| 282 | CLOV | Clover Health Investments, Corp. | 1.69B | 2.56% | 9,941,702 | 2.21B |
| 283 | NRIX | Nurix Therapeutics, Inc. | 1.68B | -1.45% | 660,434 | 71.78M |
| 284 | VCEL | Vericel Corporation | 1.68B | -1.61% | 827,670 | 292.09M |
| 285 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.72% | 794,285 | 66.05M |
| 286 | INVA | Innoviva, Inc. | 1.66B | -1.62% | 800,995 | 420.69M |
| 287 | NUVB | Nuvation Bio Inc. | 1.66B | -0.63% | 2,779,918 | 143.05M |
| 288 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.65B | 1.02% | 1,995,366 | -665.00K |
| 289 | IOVA | Iovance Biotherapeutics, Inc. | 1.65B | 2.21% | 19,047,402 | 285.61M |
| 290 | ARDX | Ardelyx, Inc. | 1.63B | -2.51% | 4,044,596 | 427.68M |
| 291 | ALMR | Alamar Biosciences, Inc. | 1.63B | -0.33% | 139,108 | 74.21M |
| 292 | ABCL | AbCellera Biologics Inc. | 1.60B | 0.19% | 13,448,736 | 75.13M |
| 293 | VIR | Vir Biotechnology, Inc. | 1.57B | 1.86% | 1,833,483 | 65.50M |
| 294 | NVAX | Novavax, Inc. | 1.56B | -6.03% | 10,343,094 | 596.34M |
| 295 | IMTX | Immatics N.V. | 1.55B | 1.50% | 519,102 | 56.67M |
| 296 | HCSG | Healthcare Services Group, Inc. | 1.53B | -3.08% | 532,524 | 1.85B |
| 297 | PRGO | Perrigo Company plc | 1.53B | -5.47% | 2,628,345 | 4.18B |
| 298 | URGN | UroGen Pharma Ltd. | 1.53B | 6.56% | 1,288,674 | 140.49M |
| 299 | PRCT | PROCEPT BioRobotics Corporation | 1.51B | 4.13% | 2,364,040 | 322.02M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.50B | 1.51% | 656,927 | - |
| 301 | AHCO | AdaptHealth Corp. | 1.50B | -0.53% | 1,838,509 | 3.29B |
| 302 | PGEN | Precigen, Inc. | 1.49B | -0.24% | 1,945,090 | 9.68M |
| 303 | ATAI | AtaiBeckley Inc. | 1.48B | 0.25% | 3,388,196 | 4.09M |
| 304 | PAHC | Phibro Animal Health Corporation | 1.47B | -9.20% | 991,420 | 1.50B |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.47B | 0.83% | 250,721 | - |
| 306 | IMCR | Immunocore Holdings plc | 1.47B | -2.47% | 157,667 | 412.81M |
| 307 | AVAH | Aveanna Healthcare Holdings Inc. | 1.43B | -2.23% | 1,079,522 | 2.43B |
| 308 | ENOV | Enovis Corporation | 1.43B | -6.56% | 1,520,919 | 2.28B |
| 309 | ARDT | Ardent Health, Inc. | 1.43B | -1.58% | 400,709 | 6.43B |
| 310 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.07% | 1,935,733 | 73.62M |
| 311 | FTRE | Fortrea Holdings Inc. | 1.42B | -2.85% | 1,196,743 | 2.71B |
| 312 | HROW | Harrow, Inc. | 1.42B | -0.50% | 1,580,977 | 268.68M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.41B | -1.96% | 546,076 | 2.50M |
| 314 | STAA | STAAR Surgical Company | 1.38B | 4.27% | 1,239,390 | 239.44M |
| 315 | MLTX | MoonLake Immunotherapeutics | 1.37B | 10.43% | 3,343,141 | - |
| 316 | BHVN | Biohaven Ltd. | 1.37B | -7.91% | 1,945,852 | - |
| 317 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 9.82% | 288,241 | - |
| 318 | WVE | Wave Life Sciences Ltd. | 1.36B | -1.53% | 3,009,380 | 71.80M |
| 319 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -1.63% | 271,247 | - |
| 320 | ATRC | AtriCure, Inc. | 1.33B | 0.08% | 924,247 | 552.16M |
| 321 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | 1.67% | 1,141,257 | - |
| 322 | GHRS | GH Research PLC | 1.32B | -0.75% | 110,475 | - |
| 323 | CMPS | COMPASS Pathways plc | 1.30B | -2.62% | 2,481,151 | - |
| 324 | PLSE | Pulse Biosciences, Inc. | 1.30B | - | 979,943 | 751.00K |
| 325 | SVRA | Savara Inc. | 1.30B | -2.10% | 1,051,647 | - |
| 326 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -0.27% | 1,306,398 | - |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.27B | 3.71% | 282,204 | 83.72M |
| 328 | TDOC | Teladoc Health, Inc. | 1.25B | -4.55% | 4,690,520 | 2.51B |
| 329 | INSP | Inspire Medical Systems, Inc. | 1.25B | -2.06% | 926,871 | 915.25M |
| 330 | AVLN | Avalyn Pharma Inc. | 1.24B | 8.20% | 306,734 | - |
| 331 | IVA | Inventiva S.A. | 1.23B | 8.01% | 1,101,062 | 7.94M |
| 332 | JBIO | Jade Biosciences, Inc. | 1.23B | -3.68% | 449,768 | - |
| 333 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.22B | -2.27% | 4,736,605 | 204.73M |
| 334 | DBVT | DBV Technologies S.A. | 1.22B | 3.19% | 173,821 | 5.74M |
| 335 | ZBIO | Zenas BioPharma, Inc. | 1.21B | 3.87% | 384,489 | 10.00M |
| 336 | PNTG | The Pennant Group, Inc. | 1.19B | -4.93% | 434,645 | 1.02B |
| 337 | WGS | GeneDx Holdings Corp. | 1.18B | -2.85% | 1,817,623 | 442.68M |
| 338 | AMN | AMN Healthcare Services, Inc. | 1.17B | 4.49% | 3,478,860 | 3.42B |
| 339 | EYPT | EyePoint, Inc. | 1.17B | 2.34% | 989,494 | 7.61M |
| 340 | AVNS | Avanos Medical, Inc. | 1.16B | 0.04% | 789,002 | 715.90M |
| 341 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | -5.26% | 495,727 | 796.33M |
| 342 | AORT | Artivion, Inc. | 1.16B | -6.30% | 1,813,452 | 458.69M |
| 343 | NEO | NeoGenomics, Inc. | 1.13B | -3.35% | 1,793,371 | 745.97M |
| 344 | ALVO | Alvotech | 1.12B | 10.12% | 606,804 | 562.04M |
| 345 | CDNA | CareDx, Inc. | 1.11B | -1.24% | 507,108 | 412.82M |
| 346 | NNNN | Anbio Biotechnology | 1.11B | -1.90% | 19,881 | 8.65M |
| 347 | COAG | Hemab Therapeutics Holdings, Inc. | 1.10B | -0.48% | 239,347 | - |
| 348 | BFLY | Butterfly Network, Inc. | 1.10B | 0.96% | 3,626,721 | 102.92M |
| 349 | EVO | Evotec SE | 1.09B | -0.33% | 63,586 | 859.03M |
| 350 | IART | Integra LifeSciences Holdings Corporation | 1.09B | 0.36% | 1,532,971 | 1.64B |
| 351 | IRMD | IRADIMED CORPORATION | 1.08B | -2.28% | 67,889 | 86.28M |
| 352 | ATEC | Alphatec Holdings, Inc. | 1.07B | -7.05% | 5,109,504 | 787.08M |
| 353 | BLFS | BioLife Solutions, Inc. | 1.06B | -1.41% | 338,371 | 101.66M |
| 354 | CNMD | CONMED Corporation | 1.06B | -4.16% | 497,691 | 1.37B |
| 355 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | -5.97% | 2,513,005 | 314.85M |
| 356 | SEPN | Septerna, Inc. | 1.06B | -1.26% | 132,899 | 72.26M |
| 357 | MNKD | MannKind Corporation | 1.04B | -4.55% | 7,537,876 | 360.78M |
| 358 | OMER | Omeros Corporation | 1.04B | 1.63% | 800,492 | - |
| 359 | CRON | Cronos Group Inc. | 1.03B | 8.27% | 4,655,834 | 159.54M |
| 360 | TNDM | Tandem Diabetes Care, Inc. | 1.01B | -4.59% | 3,647,418 | 1.03B |
| 361 | AKTS | Aktis Oncology, Inc. | 1.01B | -1.77% | 134,313 | 8.28M |
| 362 | INNV | InnovAge Holding Corp. | 999.02M | -2.77% | 587,059 | 949.17M |
| 363 | AGL | agilon health, inc. | 994.52M | 9.92% | 703,923 | 5.82B |
| 364 | SANA | Sana Biotechnology, Inc. | 987.90M | 1.42% | 2,270,500 | - |
| 365 | LXRX | Lexicon Pharmaceuticals, Inc. | 978.70M | 15.50% | 13,977,932 | 69.64M |
| 366 | LMRI | Lumexa Imaging Holdings, Inc. | 976.48M | -2.50% | 625,618 | 1.02B |
| 367 | DSGN | Design Therapeutics, Inc. | 974.95M | 9.77% | 721,866 | - |
| 368 | PHAT | Phathom Pharmaceuticals, Inc. | 970.64M | 0.49% | 919,172 | 204.89M |
| 369 | SLS | SELLAS Life Sciences Group, Inc. | 968.80M | 4.79% | 6,382,625 | - |
| 370 | GDRX | GoodRx Holdings, Inc. | 961.84M | -2.74% | 1,927,502 | 787.89M |
| 371 | SDGR | Schrödinger, Inc. | 950.45M | -3.12% | 1,978,278 | 254.91M |
| 372 | XNCR | Xencor, Inc. | 948.27M | -0.54% | 857,050 | 97.36M |
| 373 | LBRX | LB Pharmaceuticals Inc | 937.55M | 2.27% | 78,782 | - |
| 374 | VOR | Vor Biopharma Inc. | 934.70M | 1.83% | 1,389,901 | - |
| 375 | ANNX | Annexon, Inc. | 930.63M | -0.18% | 2,275,203 | - |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 930.62M | 1.58% | 1,163,735 | - |
| 377 | PHAR | Pharming Group N.V. | 920.47M | -2.75% | 24,071 | 369.49M |
| 378 | MGTX | MeiraGTx Holdings plc | 916.48M | 0.81% | 687,224 | 81.39M |
| 379 | NUTX | Nutex Health Inc. | 914.39M | -2.77% | 137,360 | 879.95M |
| 380 | DRTS | Alpha Tau Medical Ltd. | 910.02M | 21.50% | 4,924,759 | - |
| 381 | CGEM | Cullinan Therapeutics, Inc. | 905.28M | 1.24% | 875,927 | - |
| 382 | USPH | U.S. Physical Therapy, Inc. | 904.30M | 0.22% | 335,459 | 787.69M |
| 383 | ABSI | Absci Corporation | 901.13M | -2.03% | 6,371,133 | 1.84M |
| 384 | PCRX | Pacira BioSciences, Inc. | 894.77M | -1.77% | 895,966 | 734.86M |
| 385 | GERN | Geron Corporation | 891.71M | - | 32,391,608 | 196.12M |
| 386 | OMDA | Omada Health, Inc. | 873.30M | -0.88% | 1,442,832 | 283.30M |
| 387 | INMD | InMode Ltd. | 872.45M | -1.36% | 1,373,390 | 374.64M |
| 388 | JANX | Janux Therapeutics, Inc. | 867.81M | 0.35% | 914,948 | 13.73M |
| 389 | TALK | Talkspace, Inc. | 867.12M | - | 1,902,557 | 238.37M |
| 390 | ABUS | Arbutus Biopharma Corporation | 864.57M | 1.15% | 767,301 | 14.08M |
| 391 | ANRO | Alto Neuroscience, Inc. | 859.84M | 1.11% | 389,449 | - |
| 392 | SPRY | ARS Pharmaceuticals, Inc. | 853.99M | -1.60% | 1,296,456 | 84.28M |
| 393 | TBPH | Theravance Biopharma, Inc. | 851.66M | -2.88% | 410,517 | 109.78M |
| 394 | BVS | Bioventus Inc. | 851.22M | -2.95% | 450,625 | 576.30M |
| 395 | AURA | Aura Biosciences, Inc. | 850.05M | -2.50% | 333,975 | - |
| 396 | OPK | OPKO Health, Inc. | 845.70M | -1.75% | 1,625,885 | 581.12M |
| 397 | KURA | Kura Oncology, Inc. | 844.13M | 0.96% | 1,181,803 | 67.48M |
| 398 | CTMX | CytomX Therapeutics, Inc. | 840.30M | -3.02% | 3,647,699 | 35.54M |
| 399 | DRUG | Bright Minds Biosciences Inc. | 836.91M | 1.23% | 149,007 | - |
| 400 | EVMN | Evommune, Inc. | 835.99M | 1.27% | 668,351 | 10.00M |
| 401 | AZTA | Azenta, Inc. | 827.34M | -6.61% | 1,044,448 | 596.48M |
| 402 | ODTX | Odyssey Therapeutics, Inc. | 823.19M | 6.27% | 427,000 | 2.98M |
| 403 | ETON | Eton Pharmaceuticals, Inc. | 816.42M | 0.64% | 230,751 | 79.95M |
| 404 | SSII | SS Innovations International, Inc. | 815.76M | 5.43% | 36,478 | 42.48M |
| 405 | AMPH | Amphastar Pharmaceuticals, Inc. | 813.51M | -2.89% | 1,359,764 | 720.53M |
| 406 | SPTX | Seaport Therapeutics, Inc. | 808.67M | -4.98% | 399,483 | - |
| 407 | BIOA | BioAge Labs, Inc. | 807.26M | 0.94% | 509,420 | 10.32M |
| 408 | ESPR | Esperion Therapeutics, Inc. | 805.76M | -0.32% | 19,798,116 | 418.24M |
| 409 | SGP | SpyGlass Pharma, Inc. | 794.21M | 1.50% | 25,554 | - |
| 410 | CERT | Certara, Inc. | 786.56M | -18.70% | 8,081,520 | 419.75M |
| 411 | ALLO | Allogene Therapeutics, Inc. | 784.27M | - | 4,503,825 | 22.00K |
| 412 | RLMD | Relmada Therapeutics, Inc. | 771.98M | 0.55% | 894,483 | - |
| 413 | CBLL | CeriBell, Inc. | 759.72M | -0.69% | 306,854 | 95.07M |
| 414 | SLDB | Solid Biosciences Inc. | 755.81M | 5.64% | 972,361 | - |
| 415 | EHAB | Enhabit, Inc. | 705.89M | -0.07% | 646,773 | 1.06B |
| 416 | TENX | Tenax Therapeutics, Inc. | 703.60M | 2.49% | 1,382,557 | - |
| 417 | ACRS | Aclaris Therapeutics, Inc. | 691.34M | 0.41% | 1,814,440 | 8.37M |
| 418 | IRWD | Ironwood Pharmaceuticals, Inc. | 686.44M | -1.18% | 2,267,647 | 361.51M |
| 419 | QDEL | QuidelOrtho Corporation | 679.18M | -7.78% | 2,477,199 | 2.66B |
| 420 | HSTM | HealthStream, Inc. | 675.46M | -3.51% | 323,581 | 311.78M |
| 421 | BWAY | BrainsWay Ltd. | 669.50M | -2.56% | 197,535 | 52.23M |
| 422 | FBRX | Forte Biosciences, Inc. | 659.40M | 8.24% | 436,014 | - |
| 423 | TLRY | Tilray Brands, Inc. | 657.25M | -0.90% | 3,616,108 | 858.28M |
| 424 | TRAX | First Tracks Biotherapeutics, Inc. | 651.89M | -3.99% | 345,550 | - |
| 425 | STRO | Sutro Biopharma, Inc. | 651.28M | -2.31% | 198,259 | 102.48M |
| 426 | CADL | Candel Therapeutics, Inc. | 648.44M | 5.99% | 3,892,167 | - |
| 427 | GYRE | Gyre Therapeutics, Inc. | 647.83M | -5.09% | 59,914 | 117.05M |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 638.44M | -2.96% | 2,235,093 | 122.29M |
| 429 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 631.46M | 3.00% | 468,106 | - |
| 430 | AVR | Anteris Technologies Global Corp. | 629.54M | -1.06% | 821,098 | 1.91M |
| 431 | KYTX | Kyverna Therapeutics, Inc. | 625.88M | 10.59% | 1,295,805 | - |
| 432 | ARVN | Arvinas, Inc. | 623.24M | -4.45% | 1,421,478 | 89.40M |
| 433 | CABA | Cabaletta Bio, Inc. | 622.85M | -1.55% | 5,306,174 | - |
| 434 | CBIO | Crescent Biopharma, Inc. | 615.40M | -1.28% | 549,556 | 11.88M |
| 435 | VALN | Valneva SE | 611.89M | 12.70% | 116,637 | 205.07M |
| 436 | PSNL | Personalis, Inc. | 605.29M | -3.34% | 1,614,414 | 64.52M |
| 437 | CRMD | CorMedix Inc. | 600.87M | -3.28% | 1,112,420 | 311.71M |
| 438 | ALT | Altimmune, Inc. | 600.08M | - | 2,937,164 | 41.00K |
| 439 | AGMB | AgomAb Therapeutics NV | 599.84M | 0.41% | 119,424 | - |
| 440 | PRME | Prime Medicine, Inc. | 585.20M | 0.93% | 3,193,933 | 4.03M |
| 441 | PHR | Phreesia, Inc. | 581.50M | -5.90% | 984,218 | 480.59M |
| 442 | CSTL | Castle Biosciences, Inc. | 577.48M | -3.98% | 627,203 | 339.92M |
| 443 | DNA | Ginkgo Bioworks Holdings, Inc. | 566.36M | -2.91% | 1,620,624 | 151.40M |
| 444 | FDMT | 4D Molecular Therapeutics, Inc. | 564.06M | 6.41% | 1,021,746 | 88.24M |
| 445 | AVTX | Avalo Therapeutics, Inc. | 540.97M | -6.12% | 2,881,491 | 59.00K |
| 446 | AQST | Aquestive Therapeutics, Inc. | 539.39M | 0.46% | 1,387,465 | 44.55M |
| 447 | TCMD | Tactile Systems Technology, Inc. | 539.09M | -6.82% | 588,012 | 343.52M |
| 448 | EIKN | Eikon Therapeutics, Inc. | 538.68M | -0.10% | 634,769 | - |
| 449 | PROK | ProKidney Corp. | 534.47M | -4.84% | 1,329,657 | 893.00K |
| 450 | CTKB | Cytek Biosciences, Inc. | 532.07M | -10.63% | 1,113,117 | 204.17M |
| 451 | NPCE | NeuroPace, Inc. | 532.00M | -14.60% | 523,563 | 99.99M |
| 452 | CLYM | Climb Bio, Inc. | 531.19M | -2.20% | 1,248,701 | - |
| 453 | STTK | Shattuck Labs, Inc. | 530.58M | 2.48% | 452,707 | 1.00M |
| 454 | MDXG | MiMedx Group, Inc. | 530.25M | -1.11% | 2,452,447 | 389.42M |
| 455 | IMMX | Immix Biopharma, Inc. | 525.88M | 1.74% | 658,634 | - |
| 456 | RGNX | REGENXBIO Inc. | 520.30M | -4.45% | 1,581,495 | 170.44M |
| 457 | TECX | Tectonic Therapeutic, Inc. | 519.28M | -5.10% | 548,549 | - |
| 458 | ANL | Adlai Nortye Ltd. | 518.40M | -2.41% | 187,270 | 5.00M |
| 459 | SIBN | SI-BONE, Inc. | 513.67M | -5.38% | 1,752,774 | 206.22M |
| 460 | CTNM | Contineum Therapeutics, Inc. | 509.64M | -6.06% | 149,537 | - |
| 461 | PRTA | Prothena Corporation plc | 506.26M | -9.88% | 932,830 | 57.94M |
| 462 | CTEV | Claritev Corporation | 505.47M | 9.81% | 203,509 | 978.76M |
| 463 | CERS | Cerus Corporation | 504.93M | -3.45% | 2,124,164 | 216.56M |
| 464 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 465 | OCGN | Ocugen, Inc. | 501.00M | -1.99% | 9,629,029 | 4.47M |
| 466 | KMDA | Kamada Ltd. | 497.12M | -1.17% | 57,805 | 180.46M |
| 467 | UPB | Upstream Bio, Inc. | 495.77M | 0.22% | 618,895 | 2.85M |
| 468 | XOMA | XOMA Royalty Corporation | 494.50M | -0.93% | 119,368 | 52.15M |
| 469 | SRTA | Strata Critical Medical, Inc. | 489.74M | 1.62% | 1,563,336 | 228.58M |
| 470 | RIGL | Rigel Pharmaceuticals, Inc. | 484.75M | 0.61% | 377,019 | 299.77M |
| 471 | ASMB | Assembly Biosciences, Inc. | 483.29M | 2.25% | 87,317 | 71.10M |
| 472 | PRLD | Prelude Therapeutics Incorporated | 482.77M | -1.23% | 343,725 | 12.14M |
| 473 | OVID | Ovid Therapeutics Inc. | 482.77M | -0.36% | 3,794,439 | 7.25M |
| 474 | NGNE | Neurogene Inc. | 482.37M | 0.36% | 116,644 | 925.00K |
| 475 | LXEO | Lexeo Therapeutics, Inc. | 480.55M | 4.97% | 965,019 | - |
| 476 | SGMT | Sagimet Biosciences Inc. | 474.87M | -0.26% | 896,934 | - |
| 477 | OFIX | Orthofix Medical Inc. | 471.72M | 0.17% | 375,412 | 825.37M |
| 478 | FULC | Fulcrum Therapeutics, Inc. | 466.43M | -0.14% | 633,954 | 80.00M |
| 479 | EBS | Emergent BioSolutions Inc. | 461.79M | -5.79% | 633,564 | 676.80M |
| 480 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.40M | -0.40% | 53,497 | - |
| 481 | ANGO | AngioDynamics, Inc. | 451.83M | -3.21% | 452,742 | 313.73M |
| 482 | ZURA | Zura Bio Limited | 450.68M | -0.84% | 1,125,308 | - |
| 483 | FLGT | Fulgent Genetics, Inc. | 449.30M | -0.88% | 492,785 | 320.35M |
| 484 | ENTA | Enanta Pharmaceuticals, Inc. | 448.64M | 0.78% | 298,487 | 69.21M |
| 485 | LYEL | Lyell Immunopharma, Inc. | 447.98M | -0.67% | 97,142 | 31.00K |
| 486 | EVH | Evolent Health, Inc. | 445.43M | -5.26% | 4,666,170 | 1.89B |
| 487 | ADCT | ADC Therapeutics SA | 442.63M | -0.57% | 1,100,241 | 79.18M |
| 488 | CATX | Perspective Therapeutics, Inc. | 442.39M | 3.19% | 1,134,827 | 618.00K |
| 489 | KIDS | OrthoPediatrics Corp. | 441.27M | -3.54% | 238,116 | 243.30M |
| 490 | BBNX | Beta Bionics, Inc. | 438.93M | 2.07% | 701,363 | 110.24M |
| 491 | MNPR | Monopar Therapeutics Inc. | 438.47M | 3.05% | 166,548 | - |
| 492 | PRTC | PureTech Health plc | 437.17M | 1.81% | 33,106 | 4.66M |
| 493 | WEAV | Weave Communications, Inc. | 436.82M | -7.58% | 1,150,003 | 248.72M |
| 494 | AVIR | Atea Pharmaceuticals, Inc. | 432.95M | -0.37% | 358,829 | - |
| 495 | CGC | Canopy Growth Corporation | 431.88M | 0.90% | 6,414,276 | 203.04M |
| 496 | VSTM | Verastem, Inc. | 428.82M | -0.20% | 3,083,327 | 49.59M |
| 497 | IVVD | Invivyd, Inc. | 427.03M | 0.67% | 2,834,879 | 53.43M |
| 498 | LRMR | Larimar Therapeutics, Inc. | 424.88M | 3.02% | 1,826,516 | - |
| 499 | CCRN | Cross Country Healthcare, Inc. | 424.20M | -0.46% | 933,805 | 1.00B |
| 500 | NRC | NRC Health | 421.66M | -0.21% | 85,352 | 138.64M |